The new "efficiency gains" associated with doing away with images may sound like clever marketing sloganeering, but I do have an uneasy feeling about Illumina trying to close their system. As a group of bioinformatics researchers I would think open source is the way we want things and closing off systems will only serve to stifle research. I happily admit to have made use of images to salvage runs, but even good runs can be noticeably improved with open source methods. So I certainly am troubled, what about others?
Unconfigured Ad
Collapse
X
-
I have to say that I agree, but for slightly different reasons. It's not so much the closed system which worries me (I find that the Illumina pipeline actually works very well), but losing the ability to salvage runs which had problems.Originally posted by zero View PostThe new "efficiency gains" associated with doing away with images may sound like clever marketing sloganeering, but I do have an uneasy feeling about Illumina trying to close their system. As a group of bioinformatics researchers I would think open source is the way we want things and closing off systems will only serve to stifle research. I happily admit to have made use of images to salvage runs, but even good runs can be noticeably improved with open source methods. So I certainly am troubled, what about others?
We've had several runs which, had we not had access to the original images, would have been complete failures, but which we were able to successfully recover. In some cases you could just rerun the sample, but sometimes it's not that simple (scarce samples, time pressures, unusual runs etc). I'm wary about moving to the latest SCS since, with our current hardware, we won't be able to save images and this increases the chances of us losing data.
I should say, we don't keep images for long. Once we know that we have a reasonable amount of data from a lane and that it looks sensible we delete the images. The impact on our infrastructure is therefore very small, but the extra redundancy it provides is invaluable.
Comment
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
Yesterday, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
71 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Comment